UltraPse About A universal and extensible software platform for biological sequence representations

Introduction

With the avalanche of biological sequences in public databases, one of the most challenging problems in computational biology is to predict their biological functions and cellular attributes. Most of the existing prediction algorithms can only handle fixed-length numerical vectors. Therefore, it is important to be able to represent biological sequences with various lengths using fixed-length numerical vectors. Although several algorithms, as well as software implementations, have been developed to address this problem, these existing programs can only provide a fixed number of representation modes. Every time a new sequence representation mode is developed, a new program will be needed. In this paper, we propose the UltraPse as a universal software platform for this problem. The function of the UltraPse is not only to generate various existing sequence representation modes, but also to simplify all future programming works in developing novel representation modes. The extensibility of UltraPse is particularly enhanced. It allows the users to define their own representation mode, their own physicochemical properties, or even their own types of biological sequences. Moreover, UltraPse is also the fastest software of its kind.

Publications

  1. UltraPse: A Universal and Extensible Software Platform for Representing Biological Sequences
    Pu-Feng Du, Wei Zhao, Yang-Yang Miao, Le-Yi Wei, Likun Wang, 2017.11.14 - International Journal of Molecular Sciences

Credits

  1. Pu-Feng Du pdu@tju.edu.cn
    Investigator

    College of Intelligence and Computing, Tianjin University, China

Community Ratings

UsabilityEfficiencyReliabilityRated By
0 user
Sign in to rate
Summary
AccessionBT007263
Tool TypeApplication
CategoryPseAA composition
PlatformsLinux/Unix
TechnologiesC++
User InterfaceTerminal Command Line
Input DataFASTA
Latest Release1.0 (September 15, 2021)
Download Count1600
Country/RegionChina
Submitted ByShaoliang Peng
Fundings

2018YFC0910400